Sort
261,768 grants matching “gene therapy”
Modulation of Therapeutic Response
$1,121,091James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers-- Targeting the PARP Pathway for the Prevention of Breast Cancer
$1,121,090Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2022 · CA
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment
$1,120,958Jyothi Rengarajan · Emory University · R01 · FY2025 · AI
Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study
$1,120,842Sara Auld · Emory University · R01 · FY2023 · AI
Preservation &Replacement of Beta Cells in IDDM
$1,120,613Yeshiva University · P01 · FY2003 · DK
Molecular Genetics Support to Identify Gene/Environment Interactions in Disease
$1,120,556John A. Cidlowski · National Institute Of Environmental Health Sciences · ZIC · FY2016 · ES
Prospective studies on Parkinson's disease
$1,120,336Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Susceptibility Patterns for Grade C Periodontitis in Young Individuals
$1,120,085Luciana Macchion Shaddox · University Of Kentucky · U01 · FY2023 · DE
MULTICENTER CLINICAL STUDY OF ALS GENETICS
$1,120,060Northwestern University · R01 · FY2001 · NS
Transgenic Models for Prostate and Breast Cancer
$1,120,018Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2023 · AI
Harnessing Proteins as Drugs: the Protectome of Cancer- and Aging-Prevention Proteins
$1,120,000Susan M. Rosenberg · Baylor College Of Medicine · DP1 · FY2024 · AG
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2022 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2020 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2019 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2021 · AI
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
$1,119,939David M Holtzman · Washington University · P01 · FY2016 · NS
CODA Assembly of Mutant Genes
$1,119,744She-Pin Hung · Verdezyne, Inc. · R42 · FY2009 · AI
IMPROVING CARDIORESPIRATORY PERFORMANCE IN DMD VIA COMBINATORIAL DYSTROPHIN AND RIBONUCLEOTIDE REDUCTASE GENE THERAPY
$1,119,658University Of Washington · · FY2018 · Defense Health Agency
Microparticle Therapy for Cerebral Amyloid Angiopathy
$1,119,539Wolff M. Kirsch · Karamedica, Inc. · R44 · FY2021 · AG
MPD Clinical Consortium
$1,119,503Lewis Silverman · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · CA
CAREER: Characterization and Development of Prokaryotic Argonautes for Synthetic Biology
$1,119,371Kevin Solomon · University Of Delaware · · FY2022 · BIO
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,119,254Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2018 · AG
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,119,180Trever G Bivona · University Of California, San Francisco · U54 · FY2022 · CA
SPORE in Pancreatic Cancer
$1,119,167James L Abbruzzese · University Of Tx Md Anderson Can Ctr · P20 · FY2006 · CA